Pharmacological Intervention in the Elderly Phase 2 (PIE2)

Long Name: Pharmacological Intervention in the Elderly Phase 2 (PIE2)

PIE-II is a completed randomized controlled blinded trial of 9 months of standard aldosterone antagonist (spironolactone) in elderly patients (mean age 70 years) with chronic heart failure and preserved systolic function. The primary outcome was physical performance, assess by formal staged exercise ergometry test with expired gas analysis for peak VO2, as well as 6 minute walk, and SPPB. The main secondary outcome was quality of life. Mechanistic maeausres were Doppler-Echocardiogram and cardiac MRI for measures of cardiac anatomy and function and vascular stiffness. Body composition was assessed by DEXA and MRI. Skeletal muscle biopsies were obtained in some patients. Blood was stored.

Quick Reference

Gerontology and Geriatric Medicine

Geriatric Administration
336-713-8570
Geriatric Clinic
336-713-8250
Geriatric Research
336-713-8539
Elder Law Clinic
336-713-8630

Find A Doctor Ways to Give
Last Updated: 10-21-2013
USNWR 2013-2014Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.